GILBERT POON: Open Payments
NPI 1265465900 · PARSIPPANY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,246 in 74 payments from 14 companies in 2025. Trend: 2023 $898 · 2024 $1,027 · 2025 $1,246
Food & beverage: $1,246
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $241 |
| Novo Nordisk Inc | 24 | $219 |
| AstraZeneca Pharmaceuticals LP | 9 | $181 |
| Exact Sciences Corporation | 5 | $137 |
| GlaxoSmithKline, LLC. | 6 | $115 |
| Amgen Inc. | 6 | $94 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| ABBVIE INC. | 3 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
Products named: Ozempic, BREZTRI, Cologuard Collection Kit, JARDIANCE, OTEZLA, Kerendia, TRELEGY ELLIPTA, Wegovy.
Industry payments across NJ — which companies pay providers there.
